Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.
BMC Nephrol
; 16: 111, 2015 Jul 22.
Article
in En
| MEDLINE
| ID: mdl-26198842
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glomerulosclerosis, Focal Segmental
/
Anti-Inflammatory Agents, Non-Steroidal
/
Adalimumab
/
Galactose
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
BMC Nephrol
Journal subject:
NEFROLOGIA
Year:
2015
Type:
Article
Affiliation country:
United States